WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009136997) INHIBITORS OF HUMAN CATHEPSIN L, CATHEPSIN B, AND CATHEPSIN S
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/136997    International Application No.:    PCT/US2009/002412
Publication Date: 12.11.2009 International Filing Date: 17.04.2009
IPC:
A61K 31/535 (2006.01)
Applicants: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA [US/US]; Center For Technology Transfer Suite 200 3160 Chestnut Street Philadelphia, PA 19104-6283 (US) (For All Designated States Except US).
DIAMOND, Scott, L. [US/US]; (US) (For US Only).
BEAVERS, Mary, Pat [US/US]; (US) (For US Only).
HURYN, Donna [US/US]; (US) (For US Only).
MYERS, Michael, C. [US/US]; (US) (For US Only).
SMITH, Amos, B. [US/US]; (US) (For US Only).
SHAH, Parag, P. [US/US]; (US) (For US Only).
LIU, Zhuqing [CN/US]; (US) (For US Only)
Inventors: DIAMOND, Scott, L.; (US).
BEAVERS, Mary, Pat; (US).
HURYN, Donna; (US).
MYERS, Michael, C.; (US).
SMITH, Amos, B.; (US).
SHAH, Parag, P.; (US).
LIU, Zhuqing; (US)
Agent: DOYLE, Kathryn; (US)
Priority Data:
61/124,549 17.04.2008 US
61/124,521 17.04.2008 US
Title (EN) INHIBITORS OF HUMAN CATHEPSIN L, CATHEPSIN B, AND CATHEPSIN S
(FR) INHIBITEURS DES CATHEPSINES L, B ET S HUMAINES
Abstract: front page image
(EN)The present invention is directed to novel protease inhibitors that are specific for cathepsin L, cathepsin B, and cathepsin S. Accordingly, the present invention encompasses compositions and methods for treating and preventing diseases and disorders associated with cathepsin L, cathepsin B, or cathepsin S function or activity.
(FR)L’invention concerne de nouveaux inhibiteurs de protéases, spécifiques de la cathepsine L, de la cathepsine B et de la cathepsine S. L’invention concerne plus particulièrement des compositions et des méthodes de prévention et de traitement des maladies et troubles associés à la fonction ou l’activité de la cathepsine L, B ou S.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)